Actively Recruiting
Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease (riskINN)
Led by Medical University Innsbruck · Updated on 2024-11-21
5000
Participants Needed
2
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are working to create risk prediction models that help identify patients with a high risk of developing serious cardiovascular problems. The study focuses on individuals with structural, rhythm-related, or inflammatory cardiovascular diseases and aims to improve early detection of those at risk. This observational study is sponsored by the Medical University Innsbruck and includes adults 18 years and older. Participants in this study have their clinical data and risk factors recorded to better understand their cardiovascular condition. There are no specific treatments or interventions given as part of the study since it is observational. The study will follow patients for up to four years to observe outcomes related to cardiovascular events and hospitalizations. During the study, researchers will monitor events such as cardiovascular mortality, stroke, heart attacks, hospital stays due to heart failure, and other severe heart-related conditions. Participants will be assessed regularly through clinical data collection without additional procedures or treatments. The study aims to gather detailed information over time to improve risk assessment and patient care for cardiovascular diseases.
CONDITIONS
Brief Title
"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease"
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients 18 years of age or older
- Acute or chronic structural, rhythmologic, or inflammatory cardiovascular disease
- Ability and willingness to provide informed consent for participation
You will not qualify if you...
- Missing informed consent
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 4 years
Participants with cardiovascular diseases are observed with clinical data recorded, especially risk parameters, to monitor cardiovascular outcomes.
Visits scheduled according to clinical follow-up and event occurrence
Trial Site Locations
Total: 2 locations
1
Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin III, Kardiologie & Angiologie
Innsbruck, Tyrol, Austria, 6020
Actively Recruiting
2
Reha Zentrum Münster
Münster, Tyrol, Austria, 6232
Actively Recruiting
Research Team
A
Axel Bauer, Univ.-Prof. Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here